Identification of protein candidates for developing bacterial ghost vaccines against Brucella

Methods of Biochemical Analysis

Volumn 49, Issue , 2006, Pages 363-377

  Delvecchio, Vito G ^a   Alefantis, Tim ^a   Ugalde, Rodolfo A ^b   Comerci, Diego ^b   Marchesini, Maria Ines ^b   Khan, Akbar ^c   Lubitz, Werner ^d   Mujer, Cesar V ^a  

^a Vital Probes   (United States)

^b UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^c DEFENSE THREAT REDUCTION AGENCY   (United States)

^d Biotech Innovation Research Development and Consulting GmbH and Co KEG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BRUCELLA VACCINE;

BRUCELLA; BRUCELLA MELITENSIS; CHEMISTRY; HUMAN; METABOLISM; METHODOLOGY; PROTEOMICS; REVIEW; SCANNING ELECTRON MICROSCOPY;

BACTERIAL PROTEINS; BACTERIAL VACCINES; BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA VACCINE; CHEMISTRY, PHARMACEUTICAL; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PROTEOMICS;

EID: 84872156934     PISSN: 00766941     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (79)

1. Al-Mariri, A., Tiber, A., Lestrate, P., Mertens, P., De Bolle, X., and Letesson, J. J. (2002). Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen. Infec. Immun. 70:1915-1923.
2. Bowden, R. A., Cloeckaert, A., Zygmunt, M. S., and Dubray, G. (1998). Evaluation of immunogenicity and protective activity in BALB/c mice of the 25 kDa major outer membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli. J. Med. Microbiol. 47:39-48.
3. Boschiroli, M. L., Foulongne, V., and O'Callaghan, D. (2001). Brucellosis, a worldwide zoonosis. Curr. Opin. Microbiol. 4:58-64.
4. Bricker, B. J., Tabatabai, L. B., Deyoe, B. L., and Mayfield, J. E. (1988). Conservation and antigenicity in a 31-kDa Brucella protein. Vet. Microbiol. 18:313-325.
5. Bricker, B. J., Ewalt, D. S., MacMillan, A. P., Foster, G., and Brew, S. (2000). Molecular characterization of Brucella strains isolated from marine mammals. J. Clin. Microbiol. 38:1258-1262.
6. Celli, J., de Chastellier, C., Franchini, D. M., Pizarro-Cerda, J., Moreno, E., and Gorvel, J. P. (2003). Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198:545-556.
7. Celli, J., and Gorvel, J. P. (2004). Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr. Opin. Microbiol. 7:93-97.
8. Cespedes, S., Andrews, E., Folch, H., and Oñate, A. (2000). Identification and partial characterization of a new protective antigen of Brucella abortus. J. Med. Microbiol. 49:165-170.
9. Chirhart-Gilleland, R. L., Kovach, M. E., Elzer, P. H., Jennings, S. R., and Roop II, R. M. (1998). Identification and characterization of a 14-kilodalton Brucella abortus protein reactive with antibodies from naturally and experimentally infected hosts and T lymphocytes from experimentally infected BALB/c mice. Infect. Immun. 66:4000-4003.
10. Comerci, D. J., Martinez-Lorenzo, M. J., Sieira, R., Gorvel, J. P., and Ugalde, R. A. (2001). Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole. Cell. Microbiol. 3:159-168.
11. Contreras-Rodriguez, A., Ramirez-Zavala, B., Contreras, A., Schurig, G. G., Sriranganathan, N., and Lopez-Merino, A. (2003). Purification and characterization of an immunogenic aminopeptidase of Brucella melitensis. Infect. Immun. 71:5238-5244.
12. Corbel, M. J. (1997). Brucellosis: An overview. Emerg. Infect. Dis. 3:213-221.
13. Corbel, M. J., and Brinley-Morgan, W. J. (1984). Genus Brucella Meyer and Shaw 1920, 173AL. In N. R. Krieg and J. G. Holt (Eds.), Bergey's Manual of Systematic Bacteriology, Vol. 1. Baltimore, MD: Williams & Wilkins, pp. 377-388.
14. Debbarh, H. S., Zygmunt, M. S., Dubray, G., and Cloeckaert, A. (1996). Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev1 vaccinated sheep. Vet. Microbiol. 53:325-337.
15. Delrue, R. M., Martinez-Lorenzo, M., Lestrate, P., Danese, I., Bielarz, V., Mertens, P., De Bolle, X., Tibor, A., Gorvel, J. P., and Letesson, J. J. (2001). Identification of Brucella spp. genes involved in intracellular trafficking. Cell. Microbiol. 3:487-497.
16. DelVecchio, V. G., Kapatral, V., Redkar, R. J., Patra, G., Mujer, C., Los, T., Ivanova, N., Anderson, I., Bhattacharyya, A., Lykidis, A., Reznik, G., Jablonski, L., Larsen, N., D'Souza, M., Bernal, A., Mazur, M., Goltsman, E., Selkov, E., Elzer, P. H., Hagius, S., O'Callaghan, D., Letesson, J. J., Haselkorn, R., Kyrpides, N., and Overbeek, R. (2002a). The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. USA. 99:443-448.
17. DelVecchio, V. G., Wagner, M. A., Eschenbrenner, M., Horn, T. A., Kraycer, J. A., Estock, F., Elzer, P., and Mujer, C. V. (2002b). Brucella proteomes-a review. Vet. Microbiol. 90:593-603.
18. DelVecchio, V. G., Kapatral, V., Patra, G., and Mujer, C. V. (2002c). The genome of Brucella melitensis. Vet. Microbiol. 90:575-580.
19. DelVecchio, V. G., and Mujer, C. V. (2004). Comparative proteomics of Brucella species. In I. López-Goñi and I. Moriyón (Eds.), Frontier in the Molecular and Cellular Biology of Brucella. Horizon Scientific Press Norfolk, pp. 103-115.
20. Denoel, P. A., Vo, T. K., Weynants, V. E., Tibor, A., Gilson, D., Zygmunt, M. S., Limet, J. N., and Letesson, J. J. (1997a). Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB. J. Med. Microbiol. 46:801-806.
21. Denoel, P. A., Vo, T. K., Tibor, A., Weynants, V. E., Trunde, J. M., Dubray, G., Limet, J. N., and Letesson, J. J. (1997b). Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle. Infect Immun. 65:495-502.
22. Detilleux, P. G., Deyoe, B. L., and Cheville, N. F. (1990). Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro. Infect. Immun. 58:2320-2328.
23. Detilleux, P. G., Deyoe, B. L., and Cheville, N. F. (1991). Effect of endocytic and metabolic inhibitors on the internalization and intracellular growth of Brucella abortus in Vero cells. Am. J. Vet. Res. 52:1658-1664.
24. Ebensen, T., Paukner, S., Link, C., Kudela, P., De Domenico, C., Lubitz, W., and Guzman, C. A. (2004). Bacterial ghosts are an efficient delivery system for DNA vaccines. J. Immunol. 172:6858-6865.
25. Eschenbrenner, M., Wagner, M. A., Horn, T. A., Kraycer, J. A., Mujer, C. V., Hagius, S., Elzer, P., and DelVecchio, V. G. (2002). Comparative proteome analysis of Brucella melitensis vaccine strain Rev 1 and a virulent strain, 16M. J. Bacteriol. 184:4962-4970.
26. Gorvel, J. P., and Moreno, E. (2002). Brucella intracellular life: From invasion to intracellular replication. Vet. Microbiol. 90:281-297.
27. Gross, A., Terraza, A., Marchant, J., Bouaboula, M., Ouahrani-Bettache, S., Liautard, J. P., Casellas, P., and Dornand, J. (2000). A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suis. J. Leukoc. Biol. 67:335-344.
28. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17:994-999.
29. Gygi, S. P., Rist, B., Griffin, T. J., Eng, J., and Aebersold, R. (2002). Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J. Proteome Res. 1:47-54.
30. Haidinger, W., Mayr, U. B., Szostak, M. P., Resch, S., and Lubitz, W. (2003). Escherichia coli ghost production by expression of lysis geneE and Staphylococcal nuclease. Appl. Environ. Microbiol. 69:6106-6113.
31. Horn, T. A. (2002). Comparative proteomic study of Brucella melitensis strain 16M and Brucella abortus strain 2308. MS Thesis, University of Scranton, Scranton, PA.
32. Hemmen, F., Weynants, V., Scarcez, T., Letesson, J. J., and Saman, E. (1995). Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin. Diagn. Lab. Immunol. 2:263-267.
33. Jahans, K. L., Foster, G., and Broughton, E. S. (1997). The characterization of Brucella strains isolated from marine mammals. Vet. Microbiol. 57:373-382.
34. Jechlinger, X. W., Szostak, M. P., Witte, A., and Lubitz, W. (1999). Altered temperature induction sensitivity of lambda pR/cI857 system for controlled gene E expression in Escherichia coli. FEMS Microbiol Lett. 173:347-352.
35. Jones, S. M., and Winter, A. J. (1992). Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infect. Immun. 60:3011-3014.
36. Kittelberger, R., Hilbink, F., Hansen, M. F., Ross, G. P., de Lisle, G. W., Cloeckaert, A., and de Bruyn, J. (1995). Identification and characterization of immunodominant antigens during the course of infection with Brucella avis. J. Vet. Diagn. Investig. 7:210-218.
37. Ko, J., and Splitter, G. A. (2003). Molecular host-pathogen interaction in brucellosis: Current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16:65-78.
38. Kohler, S., Laysaac, M., Naroeni, A., Gentschev, I., Rittig, M., and Liautard, J. P. (2001). Secretion of listeriolysin by Brucella suis inhibits its intramacrophagic replication. Infect. Immun. 69:2753-2756.
39. Kovach, M. E., Elzer, P. H., Robertson, G. T., Chirhart-Gilleland, R. L., Christensen, M. A., Peterson, K. M., and Roop II, R. M. (1997). Cloning and nucleotide sequence analysis of a Brucella abortus gene encoding an 18 kDa immunoreactive protein. Microbial Pathogenesis. 22:241-246.
40. Letesson, J. J., Tibor, A., van Eynde, G., Wansard, V., Weynants, V., Denoel, P., and Saman, E. (1997). Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay. Clin. Diag. Lab. Immun. 4:556-564.
41. Limet, J. N., Cloeckaert, A., Bezard, G., Van Broeck, J., and Dubray, G. (1993). Antibody response to the 89 kDa outer membrane protein of Brucella in bovine brucellosis. J. Med. Microbiol. 39:403-407.
42. Lindler, L. E., Hadfield, T. L., Tall, B. D., Snellings, N. J., Rubin, F. A., Van De Verg, L. L., Hoover, D., and Warren, R. L. (1996). Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis. Infect. Immun. 64:2490-2499.
43. Lubitz, W. (2001). Bacterial ghosts as carrier and targeting systems. Exp. Opin. Biol. Ther. 1:765-771.
44. Lubitz, W., Witte, A., Eko, F. O., Kamal, M., Jechlinger, W., Brand, E., Marchart, J., Haidinger, W., Huter, V., Felnerova, D., Stralis-Alves, N., Lechleitner, S., Melzer, H., Szostak, M. P., Resch, S., Mader, H., Kuen, B., Mayr, B., Mayrhofer, P., Geretschlager, R., Haslberger, A., and Hensel, A. (1999). Extended recombinant bacterial ghost system. J. Biotechnol. 73:261-273.
45. Marchart, J., Dropmann, G., Lechleitner, S., Schlapp, T., Wanner, G., Szostak, M. P., and Lubitz, W. (2003). Pasteurella multocida- and Pasteurella haemolytica-ghosts:New vaccine candidates. Vaccine 21:3988-3997.
46. Moreno, E. (2002). Brucellosis in Central America. Vet. Microbiol. 90:31-38.
47. Mujer, C. V., Wagner, M. A., Eschenbrenner, M., Horn, T. A., Kraycer, J. A., Redkar, R., and DelVecchio, V. G. (2002). Global analysis of Brucella melitensis proteomes: Its potential use in vaccine development, identification of virulence proteins and establishing evolutionary relatedness. Ann. the N. Y. Acad. Sci. 969:97-101.
48. Mujer, C. V., Wagner, M. A., Eschenbrenner, M., Estock, F., and DelVecchio, V. G. (2003). Principles and applications of proteomics in Brucella research. In V. G. DelVecchio and V. Kremery (Eds.) Applications of Genomics and Proteomics for Analysis of Bacterial Biological Warfare Agents, Vol. 352. Amsterdam: IOS Press, pp. 25-42.
49. + T cells. Infect. Immun. 72:2081-2087.
50. Oliveira, S. C., and Splitter, G. A. (1996). Immunization of mice recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14:959-962.
51. Oliveira, S. C., Harms, J. S., Banai, M., and Splitter, G. A. (1996). Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell Immunol. 172:262-268.
52. Oñate, A. A., Céspedes, S., Cabrera, A., Rivers, R., González, A., Muñoz, C., Folch, H., and Andrews, E. (2003). A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 71:4857-4861.
53. Oñate, A. A., Vemulapalli, R., Andrews, E., Schurig, G. G., Boyle, S., and Folch, H. (1999). Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect. Immun. 67:986-988.
54. Paukner, S., Kohl, G., Jalava, K., and Lubitz, W. (2003). Sealed bacterial ghosts-novel targeting vehicles for advanced drug delivery of water-soluble substances. J. Drug Target. 11:151-161.
55. Paukner, S., Kohl, G., and Lubitz, W. (2004). Bacterial ghosts as novel advanced drug delivery systems: Antiproliferative activity of loaded doxorubicin in human Caco-2 cells. J. Control Release 94:63-74.
56. Riley, L. K., and Robertson, D. C. (1984). Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes. Infect. Immun. 46:224-230.
57. Roop II, R. M., Fletcher, T. W., Sriranganathan, N. M., Boyle, S. M., and Schurig, G. G. (1994). Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun. 62:1000-1007.
58. Roop II, R. M., Bellaire, B. H., Valderas, M. W., and Cardelli, J. A. (2004). Adaptation of the brucellae to their intracellular niche. Mol. Microbiol. 52:621-630.
59. Samartino, L. E. (2002). Brucellosis in Argentina. Vet. Microbiol. 90:71-80.
60. Sola-Landa, A., Pizarro-Cerda, J., Grillo, M. J., Moreno, E., Moriyon, I., Blasco, J. M., Gorvel, J. P., and Lopez-Goñi, I. (1998). A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol. Microbiol. 29:125-138.
61. Stevens, M. G., Olsen, S. C., Pugh, G. W., and Mayfield, J. E. (1997). Role of immune responses to a GroEL heat shock protein in preventing brucellosis in mice vaccinated with Brucella abortus strain RB51. Comp. Immunol. Microbiol. Infect. Dis. 20:147-153.
62. Szostak, M. P., Hensel, A., Eko, F. O., Klein, R., Auer, T., Mader, H., Haslberger, A., Bunka, S., Wanner, G., and Lubitz, W. (1996). Bacterial ghosts: Nonliving candidate vaccines. J. Biotechnol. 44:161-170.
63. Tabatabai, L. B., and Pugh, G. W. Jr. (1994). Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine. 12:919-924.
64. Taylor, J. P., and Perdue, J. N. (1989). The changing epidemiology of human brucellosis in Texas, 1977-1986. Am. J. Epidemiol. 130:160-165.
65. Teixeira-Gomes, A. P., Cloeckaert, A., Bézard, G., Bowden, R. A., Dubray, G., and Zygmunt, M. S. (1997a). Identification and characterization of Brucella avis immunogenic proteins using two-dimensional electrophoresis and immunoblotting. Electrophoresis. 18:1491-1497.
66. Teixeira-Gomes, A. P., Cloeckaert, A., Bézard, G., Dubray, G., and Zygmunt, M. S. (1997b). Mapping and identification of Brucella melitensis proteins by two-dimensional electrophoresis and microsequencing. Electrophoresis 18:156-162.
67. Ugalde, J. E., Comerci, D. J., Leguizamon, M. S., and Ugalde, R. A. (2003). Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine. Infect Immun. 71:6264-6269.
68. Velikovsky, C. A., Cassataro, J., Giambartolomei, G. H., Goldbaum, F. A., Estein, S., Bowden, R. A., Bruno, L., Fossati, C. A., and Spitz, M. (2002). A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun. 70:2507-2511.
69. Velikovsky, C. A., Goldbaum, F. A., Cassataro, J., Estein, S., Bowden, R. A., Bruno, L., Fossati, C. A., and Giambartolomei, G. H. (2003). Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abo7rtus 544 independently of the adjuvant formulation used. Infect. Immun. 71:5750-5755.
70. Vemulapalli, R., Duncan, A. J., Boyle, S. M., Sriranganathan, N., Toth, T. E., and Schurig, G. G. (1998). Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect Immun. 66:5684-5691.
71. Vemulapalli, R., He, Y., Cravero, S., Sriranganathan, N., Boyle, S. M., and Schurig, G. G. (2000). Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect. Immun. 68:3286-3289.
72. Verger, J. M., Grayon, M., Cloeckaert, A., Lefevre, M., Ageron, E., and Grimont, F. (2000). Classification of Brucella strains isolated from marine mammals using DNA-DNA hybridization and ribotyping. Res. Microbiol 151:797-799.
73. Verger, J. M., Grimont, F., Grimont, P. A. D., and Grayon, M. (1985). Brucella, a monospecific genus as shown by deoxyribonucleic acid hybridization. Int. J. Sys. Bact. 35:292-295.
74. Vizcaino, N., Cloeckaert, A., Dubray, G., and Zygmunt, M. S. (1996). Cloning, nucleotide sequence, and expression of the gene coding for a ribosome releasing factor-homologous protein of Brucella melitensis. Infect. Immun. 64:4834-4837.
75. Wagner, M. A., Eschenbrenner, M., Horn, T. A., Kraycer, J. A., Mujer, C. V., Hagius, S., Elzer, P., and DelVecchio, V. G. (2002). Global analysis of the Brucella melitensis proteome: Identification of proteins expressed in laboratory-grown culture. Proteomics 2:1047-1060.
76. Witte, A., Wanner, G., Blasi, U., Halfmann, G., Szostak, M., and Lubitz, W. (1990). Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein, E. J. Bacteriol. 172:4109-4114.
77. World Health Organization (WHO) (1998). The Development of New/Improved Brucellosis Vaccines, WHO document EMC/ZDI/98.14, Report of WHO Meeting, Dec. 11-12, 1997. Geneva, Switzerland: WHO, pp. 1-44.
78. Young, E. J. (1983). Human brucellosis. Rev. Infect. Dis. 5:821-842.
79. Zygmunt, M. S., Gilbert, F. B., and Dubray, G. (1992). Purification, characterization, and seroactivity of a 20-kilodalton Brucella protein antigen. J. Clin. Microbiol. 30:2662-2667.